Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127364121 | 12736412 | 1 | I | 20160904 | 20160909 | 20160913 | 20160913 | PER | US-BAYER-2016-177492 | BAYER | 40.00 | YR | A | M | Y | 64.85000 | KG | 20160913 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127364121 | 12736412 | 1 | PS | CLARITIN REDITABS | LORATADINE | 1 | UNK | Y | CVM03Y3 | 20704 | ORODISPERSIBLE TABLET | ||||||||
| 127364121 | 12736412 | 2 | SS | CLARITIN REDITABS | LORATADINE | 1 | Y | 20704 | ORODISPERSIBLE TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127364121 | 12736412 | 1 | Hypersensitivity |
| 127364121 | 12736412 | 2 | Nasopharyngitis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127364121 | 12736412 | Decreased appetite | |
| 127364121 | 12736412 | Depression | |
| 127364121 | 12736412 | Drug ineffective | |
| 127364121 | 12736412 | Fatigue | |
| 127364121 | 12736412 | Headache | |
| 127364121 | 12736412 | Mouth ulceration | |
| 127364121 | 12736412 | Nervousness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127364121 | 12736412 | 1 | 2016 | 20160907 | 0 |